Compositions and methods for treatment of virus-induced airway fibrosis
AssigneeThe United States of America, as represented by the Secretary, Dept. of Health and Human Services
InventorsPeter D. Sun, Rachel Erickson
Life of this patent
Estimating the term…
Abstract
Methods of treating or inhibiting viral infection-induced airway fibrosis in a subject, the method including administering to the subject an effective amount of a composition including one or more direct thrombin inhibitors or one or more serine protease inhibitors or metalloprotease inhibitors are provided. In some examples, the composition is administered to the subject by inhalation. In particular examples, the viral infection-induced airway fibrosis is a coronavirus infection-induced airway fibrosis.
Claims22
A method of treating or inhibiting viral infection-induced airway fibrosis in a subject, comprising administering to the subject an effective amount of a composition comprising one or more direct thrombin inhibitors.
2, The method of claim 1, wherein the viral infection-induced airway fibrosis is a coronavirus infection-induced airway fibrosis.
The method of claim 2, wherein the coronavirus is severe acute respiratory syndrome (SARS)-CoV-2.
A method of treating or inhibiting viral infection-induced airway fibrosis in a subject, comprising administering to the subject an effective amount of a composition comprising one or more serine protease inhibitors or metalloprotease inhibitors.
Dependencies are inferred from the claim text.